No change in Bcl-2, Bcl-xL, or Bax/Bak expression was observed in prostate cancer PC-3 cells in one study [65], while other authors have detected Mcl-1 degradation in liver cancer cells [66]. This evidence concerns the gene BAX and prostate carcinoma.